QL
IBRX icon

Quarry LP’s ImmunityBio IBRX Stock Holding History

Quarry LP’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Buy
+421
New +$3.19K ﹤0.01% 1249
2025
Q3 		– Sell
-3,752
Closed -$9.9K – 2320
2025
Q2 		$9.9K Buy
+3,752
New +$10.1K ﹤0.01% 1338

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quarry LP's IBRX Position: Q2 2026 in Review

Quarry LP opened a new position in ImmunityBio (IBRX) in Q2 2026: 421 shares worth $3.69K. The stake represents ﹤0.01% of the portfolio and ranks #1249 among its holdings. This is a return to the name: Quarry LP previously reported a position in IBRX as recently as Q2 2025.

Quarry LP first reported a position in IBRX in Q2 2025 and has held it in 2 quarters since. The position peaked at $9.9K in Q2 2025. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Quarry LP held 421 shares of ImmunityBio worth $3.69K as of Q2 2026.
  • ImmunityBio was a new Quarry LP position in Q2 2026.
  • ImmunityBio made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1249 holding.
  • Quarry LP first reported a position in ImmunityBio in Q2 2025 and has held it in 2 quarters since.
  • Quarry LP's ImmunityBio position peaked at $9.9K in Q2 2025.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.